ALT – Altimmune Inc
Name : Altimmune, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $0.0000
EPSttm :
[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=ALT
#%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]
[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=ALT
&conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]
Float Short %
30.4
Margin Of Safety %
Put/Call OI Ratio
0.41
EPS Next Q Diff
-0.07
EPS Last/This Y
0.07
EPS This/Next Y
-0.29
Price
3.87
Target Price
22.38
Analyst Recom
1.22
Performance Q
-27.26
Relative Volume
4.13
Beta
0.47
Ticker: ALT
20 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-06-02 | ALT | 5.29 | 0.32 | 0.30 | 210332 |
2025-06-03 | ALT | 5.41 | 0.32 | 0.25 | 218493 |
2025-06-04 | ALT | 5.49 | 0.32 | 0.33 | 223018 |
2025-06-05 | ALT | 5.49 | 0.32 | 0.33 | 233583 |
2025-06-06 | ALT | 5.61 | 0.32 | 0.55 | 238202 |
2025-06-09 | ALT | 5.95 | 0.34 | 0.73 | 235281 |
2025-06-10 | ALT | 6.73 | 0.34 | 0.40 | 240141 |
2025-06-11 | ALT | 6.53 | 0.36 | 0.59 | 252075 |
2025-06-12 | ALT | 7.15 | 0.37 | 0.34 | 259530 |
2025-06-13 | ALT | 6.91 | 0.37 | 0.83 | 264848 |
2025-06-16 | ALT | 6.87 | 0.38 | 1.66 | 254953 |
2025-06-17 | ALT | 6.87 | 0.45 | 0.53 | 275700 |
2025-06-18 | ALT | 6.78 | 0.45 | 0.58 | 287350 |
2025-06-20 | ALT | 7.02 | 0.46 | 0.59 | 295441 |
2025-06-23 | ALT | 7 | 0.47 | 1.52 | 208843 |
2025-06-24 | ALT | 7.19 | 0.54 | 0.85 | 231800 |
2025-06-25 | ALT | 7.72 | 0.57 | 0.91 | 251046 |
2025-06-26 | ALT | 3.63 | 0.59 | 0.56 | 266482 |
2025-06-27 | ALT | 3.49 | 0.49 | 1.47 | 287360 |
2025-06-30 | ALT | 3.87 | 0.41 | 0.26 | 225319 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
20 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-06-02 | ALT | 5.29 | 15.8 | -33.6 | -1.24 |
2025-06-03 | ALT | 5.42 | 15.8 | -43.3 | -1.24 |
2025-06-04 | ALT | 5.49 | 15.8 | -49.7 | -1.24 |
2025-06-05 | ALT | 5.46 | 15.8 | -46.2 | -1.24 |
2025-06-06 | ALT | 5.61 | 15.8 | -52.8 | -1.27 |
2025-06-09 | ALT | 5.95 | 14.1 | -31.6 | -1.27 |
2025-06-10 | ALT | 6.74 | 14.1 | -43.5 | -1.27 |
2025-06-11 | ALT | 6.53 | 14.1 | -17.1 | -1.27 |
2025-06-12 | ALT | 7.15 | 14.1 | -36.6 | -1.27 |
2025-06-13 | ALT | 6.91 | 14.1 | -16.8 | -1.27 |
2025-06-16 | ALT | 6.87 | 14.1 | -20.9 | -1.27 |
2025-06-17 | ALT | 6.87 | 14.1 | -23.0 | -1.27 |
2025-06-18 | ALT | 6.78 | 14.1 | -19.4 | -1.27 |
2025-06-20 | ALT | 7.03 | 14.1 | -27.5 | -1.27 |
2025-06-23 | ALT | 7.00 | 14.1 | -21.4 | -1.27 |
2025-06-24 | ALT | 7.18 | 14.1 | -26.0 | -1.27 |
2025-06-25 | ALT | 7.72 | 14.1 | -33.2 | -1.27 |
2025-06-26 | ALT | 3.60 | 14.1 | 57.0 | -1.27 |
2025-06-27 | ALT | 3.49 | 14.1 | -14.0 | -1.27 |
2025-06-30 | ALT | 3.87 | 14.1 | -46.4 | -1.27 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
20 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-06-02 | ALT | 1.32 | -5.86 | 28.25 |
2025-06-03 | ALT | 1.32 | -5.86 | 28.25 |
2025-06-04 | ALT | 1.32 | -5.86 | 28.25 |
2025-06-05 | ALT | 1.32 | -5.86 | 28.25 |
2025-06-06 | ALT | 1.32 | -5.86 | 28.25 |
2025-06-09 | ALT | 1.32 | -5.76 | 28.25 |
2025-06-10 | ALT | 1.32 | -5.76 | 28.25 |
2025-06-11 | ALT | 1.32 | -5.76 | 27.39 |
2025-06-12 | ALT | 1.32 | -5.76 | 27.39 |
2025-06-13 | ALT | 1.32 | -5.76 | 27.39 |
2025-06-16 | ALT | 1.32 | -5.65 | 27.39 |
2025-06-17 | ALT | 1.32 | -5.65 | 27.39 |
2025-06-18 | ALT | 1.32 | -5.65 | 27.39 |
2025-06-19 | ALT | 1.32 | -5.65 | 27.39 |
2025-06-20 | ALT | 1.32 | -5.65 | 27.39 |
2025-06-24 | ALT | 1.32 | -5.65 | 27.39 |
2025-06-25 | ALT | 1.32 | -5.65 | 27.39 |
2025-06-26 | ALT | 1.32 | -5.65 | 30.40 |
2025-06-27 | ALT | 1.32 | -5.65 | 30.40 |
2025-06-30 | ALT | 1.32 | -5.65 | 30.40 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
20 items
«
‹
Current Page1 of 1
›
»
[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=ALT
589 360 ]
Last Quarter Act. EPS
-0.26
Avg. EPS Est. Current Quarter
-0.3
Avg. EPS Est. Next Quarter
-0.33
Insider Transactions
1.32
Institutional Transactions
-5.65
Beta
0.47
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
26
Growth Score
33
Sentiment Score
1
Actual DrawDown %
89
Max Drawdown 5-Year %
-93.6
Target Price
22.38
P/E
Forward P/E
PEG
P/S
15693.96
P/B
2.12
P/Free Cash Flow
EPS
-1.25
Average EPS Est. Cur. Y
-1.27
EPS Next Y. (Est.)
-1.56
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-451200
Relative Volume
4.13
Return on Equity vs Sector %
-87.3
Return on Equity vs Industry %
-68.2
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.02
EBIT Estimation
-46.4
[iframe https://widget.finnhub.io/widgets/recommendation?symbol=ALT
589 450 ]
[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=ALT
589 450 ]
Sector: Healthcare
Industry: Biotechnology
Employees: 59
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
stock quote shares ALT – Altimmune Inc Stock Price stock today
news today ALT – Altimmune Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ALT – Altimmune Inc yahoo finance google finance
stock history ALT – Altimmune Inc invest stock market
stock prices ALT
premarket after hours
ticker ALT
fair value insiders trading